 |
|
|
|||||
Granules India's stock shows a slight recovery despite reporting lower profits in the June quarter. Investors are positive about the company's product pipeline and business stabilisation. The company anticipates better growth in FY27. Approvals for six products in Europe are awaited. Granules focuses on CNS, ADHD, and oncology products. The Gagillapur facility remediation is progressing well with US FDA.
Category:
News and Media
A study by DSP Mutual Fund reveals a contrarian investment strategy. It suggests that investing in the previous year's losing index yields higher returns. This outperforms chasing recent winners in the stock market. Between October 2009 and June 2025, contrarian investors earned 15.9%. Performance chasers earned 12.5% during the same period. Investing in Nifty 500 gave 13% returns.
Category:
News and Media
SEBI is considering regulating the grey market for unlisted shares, aiming to improve price discovery before IPOs and boost government tax revenue. This initiative comes as India's IPO market sees significant growth despite global economic uncertainties. SEBI plans to collaborate with the corporate affairs ministry and stock exchanges to establish a regulated pre-IPO trading platform with necessary disclosures.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||